Clinical Trial Results TV
SCARR Registry of DES vs Bare Metal Stents presented at ESC 2007
Dr. Mike Gibson reports live from ESC 2007 that the Swedish Coronary Angiography /
Angioplasty Registry (SCARR) of 35,000 patients showed no difference in mortality for
drug-eluting stents (DES) versus bare metal stents (BMS) now at four-years of follow-up.
In fact, DES were associated with a lower rate of death and myocardial infarction (MI) at
six months, but this trend reversed between six months and four years, resulting in a
neutral outcome at four years. This information is in contrast to last year's results
from the same registry that showed a higher mortality among DES patients.

[ Download video ]

Video Statistics
5 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 1 total votes.

These statistics are updated nightly. The last update ran on
06-25-2022 EST at 1 am.

Additional Files
Filename File Description Action
No additional files available

Comments [ login to comment ]
No comments have been submitted